MRNA 480m Trend Model
"It would be nice to catch one of these high flying biotechs before they take off. Are there any clues here?"
fol·low-through8:31AM MDRNA demonstrates the potential for greater efficacy in cancer with an UsiRNA combination approach (MRNA) 1.04 : Co announced enhanced efficacy for tumor reduction when two UsiRNA were combined within a single formulation. The UsiRNAs targeted two proteins survivin, a protein involved in cell division and inhibition of apoptosis, and PLK1 (Polo-like Kinase 1), a protein involved in cell mitosis and tumor progression. Both UsiRNA were encapsulated in the Company's proprietary DiLA2-based formulation, and delivered directly to the bladder (intravesical) in an orthotopic cancer model. At an equivalent total dose, tumor bioluminescence with a combination approach was significantly lower (~30%), when compared to a single UsiRNA. Additionally, the Company also announced another early collaborative effort with a major international pharmaceutical company bringing the total number of early collaborative efforts to three.
1. The act or an instance of following through;
2. Sports The concluding part of a stroke, after a ball or other object has been hit or released.
